NCT00000320View on ClinicalTrials.gov

Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 31, 1997

Primary Completion Date

August 31, 1999

Study Completion Date

August 31, 1999

Conditions
Opioid-Related Disorders
Interventions
DRUG

Buprenorphine formulation: liquid vs. tablet

random assignment to liquid buprenorphine or tablet buprenorphine

Trial Locations (1)

90025

Friends Research Institute, Los Angeles

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00000320 - Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1 | Biotech Hunter | Biotech Hunter